(Q50525853)

14 March 2018

title

Comparison of infrared spectra of CLL cells with their ex vivo sensitivity (MTT assay) to chlorambucil and cladribine. (English)

1 reference

14 March 2018

main subject

infrared spectroscopy

1 reference

1 reference

1 reference

K Z Liu

1

1 reference

14 March 2018

C P Schultz

2

1 reference

14 March 2018

J B Johnston

3

1 reference

14 March 2018

K Lee

4

1 reference

14 March 2018

H H Mantsch

5

1 reference

14 March 2018

publication date

1 November 1997

1 reference

14 March 2018

published in

Leukemia Research

1 reference

14 March 2018

volume

21

1 reference

14 March 2018

page(s)

1125-1133

1 reference

14 March 2018

issue

11-12

1 reference

14 March 2018

Chronic lymphocytic leukemia: new insights into biology and therapy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900060-X

7 January 2021

Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900060-X

7 January 2021

High complete remission rate from 2-chloro-2'-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukemia: response predicted by rapid decrease of blood lymphocyte count

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900060-X

7 January 2021

2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900060-X

7 January 2021

Metabolism and reactions of alkylating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900060-X

7 January 2021

Chlorambucil in chronic lymphocytic leukemia: mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900060-X

7 January 2021

Mechanisms of resistance to chlorambucil in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900060-X

7 January 2021

Glutathione-conferred resistance to antineoplastics: approaches toward its reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900060-X

7 January 2021

The interaction of bifunctional alkylating agents with the DNA of tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900060-X

7 January 2021

Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900060-X

7 January 2021

Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900060-X

7 January 2021

Infrared spectroscopy of DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900060-X

7 January 2021

New possibilities of research in chronic lymphatic leukemia by means of Fourier transform-infrared spectroscopy--II

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900060-X

7 January 2021

Study of chronic lymphocytic leukemia cells by FT-IR spectroscopy and cluster analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900060-X

7 January 2021

New insight into protein secondary structure from resolution-enhanced infrared spectra

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900060-X

7 January 2021

Computerized consensus diagnosis: a classification strategy for the robust analysis of MR spectra. I. Application to 1H spectra of thyroid neoplasms.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900060-X

7 January 2021

Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900060-X

7 January 2021

Mitochondrial control of nuclear apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900060-X

7 January 2021

Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900060-X

7 January 2021

Expression of Fas antigen in acute myeloid leukaemia is associated with therapeutic response to chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900060-X

7 January 2021

Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900060-X

7 January 2021

Tumor suppressor genes and clonal evolution in B-CLL.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900060-X

7 January 2021

10.1016/S0145-2126(97)00060-X

Identifiers

DOI

1 reference

14 March 2018

PubMed ID

9444947

1 reference

14 March 2018